Compile Data Set for Download or QSAR

Found 117 hits Enz. Inhib. hit(s) with all data for entry = 559   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kJ/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Interleukin-1 receptor-associated kinase 4 (Homo sapiens (Human))	BDBM278744 (2-[(3R)- or (3S)-azepan- 3-ylamino]-N-[3- (difluor...) Show SMILES OC(=O)C(F)(F)F.Cn1cc(NC(=O)c2ccc3ccc(N[C@@H]4CCCCNC4)nn23)c(n1)C(F)F |r| Show InChI InChI=1S/C19H23F2N7O.C2HF3O2/c1-27-11-14(17(26-27)18(20)21)24-19(29)15-7-5-13-6-8-16(25-28(13)15)23-12-4-2-3-9-22-10-12;3-2(4,5)1(6)7/h5-8,11-12,18,22H,2-4,9-10H2,1H3,(H,23,25)(H,24,29);(H,6,7)/t12-;/m1./s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	0.200	n/a	n/a	n/a	n/a	7.2	n/a
Merck Sharp & Dohme Corp. US Patent					Assay Description The kinase activity of IRAK4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosp...				US Patent US10040798 (2018) BindingDB Entry DOI: 10.7270/Q2F191Q7
					More data for this Ligand-Target Pair
Interleukin-1 receptor-associated kinase 4 (Homo sapiens (Human))	BDBM278745 (2-[(3R)- or (3S)-azepan- 3-ylamino]-N-[3- (difluor...) Show SMILES OC(=O)C(F)(F)F.Cn1cc(NC(=O)c2ccc3ccc(N[C@H]4CCCCNC4)nn23)c(n1)C(F)F |r| Show InChI InChI=1S/C19H23F2N7O.C2HF3O2/c1-27-11-14(17(26-27)18(20)21)24-19(29)15-7-5-13-6-8-16(25-28(13)15)23-12-4-2-3-9-22-10-12;3-2(4,5)1(6)7/h5-8,11-12,18,22H,2-4,9-10H2,1H3,(H,23,25)(H,24,29);(H,6,7)/t12-;/m0./s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	0.300	n/a	n/a	n/a	n/a	7.2	n/a
Merck Sharp & Dohme Corp. US Patent					Assay Description The kinase activity of IRAK4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosp...				US Patent US10040798 (2018) BindingDB Entry DOI: 10.7270/Q2F191Q7
					More data for this Ligand-Target Pair
Interleukin-1 receptor-associated kinase 4 (Homo sapiens (Human))	BDBM278715 (2-[(3R)-3- aminopiperidin-1-yl]-N- [1-methyl-3- (t...) Show SMILES OC(=O)C(F)(F)F.Cn1cc(NC(=O)c2ccc3ccc(nn23)N2CCC[C@@H](N)C2)c(n1)C(F)(F)F |r| Show InChI InChI=1S/C18H20F3N7O.C2HF3O2/c1-26-10-13(16(25-26)18(19,20)21)23-17(29)14-6-4-12-5-7-15(24-28(12)14)27-8-2-3-11(22)9-27;3-2(4,5)1(6)7/h4-7,10-11H,2-3,8-9,22H2,1H3,(H,23,29);(H,6,7)/t11-;/m1./s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	0.5	n/a	n/a	n/a	n/a	7.2	n/a
Merck Sharp & Dohme Corp. US Patent					Assay Description The kinase activity of IRAK4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosp...				US Patent US10040798 (2018) BindingDB Entry DOI: 10.7270/Q2F191Q7
					More data for this Ligand-Target Pair
Interleukin-1 receptor-associated kinase 4 (Homo sapiens (Human))	BDBM278716 (2-[(3R)-3- aminopiperidin-1-yl]-N- [3-(difluoromet...) Show SMILES OC(=O)C(F)(F)F.Cn1cc(NC(=O)c2ccc3ccc(nn23)N2CCC[C@@H](N)C2)c(n1)C(F)F |r| Show InChI InChI=1S/C18H21F2N7O.C2HF3O2/c1-25-10-13(16(24-25)17(19)20)22-18(28)14-6-4-12-5-7-15(23-27(12)14)26-8-2-3-11(21)9-26;3-2(4,5)1(6)7/h4-7,10-11,17H,2-3,8-9,21H2,1H3,(H,22,28);(H,6,7)/t11-;/m1./s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	0.5	n/a	n/a	n/a	n/a	7.2	n/a
Merck Sharp & Dohme Corp. US Patent					Assay Description The kinase activity of IRAK4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosp...				US Patent US10040798 (2018) BindingDB Entry DOI: 10.7270/Q2F191Q7
					More data for this Ligand-Target Pair
Interleukin-1 receptor-associated kinase 4 (Homo sapiens (Human))	BDBM278732 (2-{[(1R,2S)-2- aminocyclohexyl]amino}- N-(3-cyano-...) Show SMILES OC(=O)C(F)(F)F.Cn1cc(NC(=O)c2ccc3ccc(N[C@@H]4CCCC[C@@H]4N)nn23)c(n1)C#N |r| Show InChI InChI=1S/C19H22N8O.C2HF3O2/c1-26-11-16(15(10-20)24-26)23-19(28)17-8-6-12-7-9-18(25-27(12)17)22-14-5-3-2-4-13(14)21;3-2(4,5)1(6)7/h6-9,11,13-14H,2-5,21H2,1H3,(H,22,25)(H,23,28);(H,6,7)/t13-,14+;/m0./s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	0.700	n/a	n/a	n/a	n/a	7.2	n/a
Merck Sharp & Dohme Corp. US Patent					Assay Description The kinase activity of IRAK4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosp...				US Patent US10040798 (2018) BindingDB Entry DOI: 10.7270/Q2F191Q7
					More data for this Ligand-Target Pair
Interleukin-1 receptor-associated kinase 4 (Homo sapiens (Human))	BDBM278719 (N-[3-(difluoromethyl)- 1-methyl-1H-pyrazol-4- yl]-...) Show SMILES OC(=O)C(F)(F)F.Cn1cc(NC(=O)c2ccc3ccc(N[C@@H]4CCCNC4)nn23)c(n1)C(F)F |r| Show InChI InChI=1S/C18H21F2N7O.C2HF3O2/c1-26-10-13(16(25-26)17(19)20)23-18(28)14-6-4-12-5-7-15(24-27(12)14)22-11-3-2-8-21-9-11;3-2(4,5)1(6)7/h4-7,10-11,17,21H,2-3,8-9H2,1H3,(H,22,24)(H,23,28);(H,6,7)/t11-;/m1./s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	0.900	n/a	n/a	n/a	n/a	7.2	n/a
Merck Sharp & Dohme Corp. US Patent					Assay Description The kinase activity of IRAK4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosp...				US Patent US10040798 (2018) BindingDB Entry DOI: 10.7270/Q2F191Q7
					More data for this Ligand-Target Pair
Interleukin-1 receptor-associated kinase 4 (Homo sapiens (Human))	BDBM278749 (2-(3,8- diazabicyclo[3.2.1]oct- 3-yl)-N-[3- (diflu...) Show SMILES OC(=O)C(F)(F)F.Cn1cc(NC(=O)c2ccc3ccc(nn23)N2CC3CCC(C2)N3)c(n1)C(F)F Show InChI InChI=1S/C19H21F2N7O.C2HF3O2/c1-26-10-14(17(25-26)18(20)21)23-19(29)15-6-4-13-5-7-16(24-28(13)15)27-8-11-2-3-12(9-27)22-11;3-2(4,5)1(6)7/h4-7,10-12,18,22H,2-3,8-9H2,1H3,(H,23,29);(H,6,7)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1	n/a	n/a	n/a	n/a	7.2	n/a
Merck Sharp & Dohme Corp. US Patent					Assay Description The kinase activity of IRAK4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosp...				US Patent US10040798 (2018) BindingDB Entry DOI: 10.7270/Q2F191Q7
					More data for this Ligand-Target Pair
Interleukin-1 receptor-associated kinase 4 (Homo sapiens (Human))	BDBM278722 (2-{[(1R,2S)-2- aminocyclo- hexyl]amino}-N-[3- (dif...) Show SMILES OC(=O)C(F)(F)F.Cn1cc(NC(=O)c2ccc3ccc(N[C@@H]4CCCC[C@@H]4N)nn23)c(n1)C(F)F |r| Show InChI InChI=1S/C19H23F2N7O.C2HF3O2/c1-27-10-14(17(26-27)18(20)21)24-19(29)15-8-6-11-7-9-16(25-28(11)15)23-13-5-3-2-4-12(13)22;3-2(4,5)1(6)7/h6-10,12-13,18H,2-5,22H2,1H3,(H,23,25)(H,24,29);(H,6,7)/t12-,13+;/m0./s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1	n/a	n/a	n/a	n/a	7.2	n/a
Merck Sharp & Dohme Corp. US Patent					Assay Description The kinase activity of IRAK4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosp...				US Patent US10040798 (2018) BindingDB Entry DOI: 10.7270/Q2F191Q7
					More data for this Ligand-Target Pair
Interleukin-1 receptor-associated kinase 4 (Homo sapiens (Human))	BDBM278709 (N-[1-methyl-3- (trifluoromethyl)-1H- pyrazol-4-yl]...) Show SMILES OC(=O)C(F)(F)F.Cn1cc(NC(=O)c2ccc3ccc(N[C@@H]4CCCNC4)nn23)c(n1)C(F)(F)F |r| Show InChI InChI=1S/C18H20F3N7O.C2HF3O2/c1-27-10-13(16(26-27)18(19,20)21)24-17(29)14-6-4-12-5-7-15(25-28(12)14)23-11-3-2-8-22-9-11;3-2(4,5)1(6)7/h4-7,10-11,22H,2-3,8-9H2,1H3,(H,23,25)(H,24,29);(H,6,7)/t11-;/m1./s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1	n/a	n/a	n/a	n/a	7.2	n/a
Merck Sharp & Dohme Corp. US Patent					Assay Description The kinase activity of IRAK4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosp...				US Patent US10040798 (2018) BindingDB Entry DOI: 10.7270/Q2F191Q7
					More data for this Ligand-Target Pair
Interleukin-1 receptor-associated kinase 4 (Homo sapiens (Human))	BDBM278728 (2-{[(1R,2S)-2- aminocyclohexyl]amino}- N-(3-chloro...) Show SMILES OC(=O)C(F)(F)F.Cn1cc(NC(=O)c2ccc3ccc(N[C@@H]4CCCC[C@@H]4N)nn23)c(Cl)n1 |r| Show InChI InChI=1S/C18H22ClN7O.C2HF3O2/c1-25-10-14(17(19)24-25)22-18(27)15-8-6-11-7-9-16(23-26(11)15)21-13-5-3-2-4-12(13)20;3-2(4,5)1(6)7/h6-10,12-13H,2-5,20H2,1H3,(H,21,23)(H,22,27);(H,6,7)/t12-,13+;/m0./s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1	n/a	n/a	n/a	n/a	7.2	n/a
Merck Sharp & Dohme Corp. US Patent					Assay Description The kinase activity of IRAK4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosp...				US Patent US10040798 (2018) BindingDB Entry DOI: 10.7270/Q2F191Q7
					More data for this Ligand-Target Pair
Interleukin-1 receptor-associated kinase 4 (Homo sapiens (Human))	BDBM278727 (2-(azepan-3-ylamino)- N-[3-(difluoromethyl)- 1-met...) Show SMILES OC(=O)C(F)(F)F.Cn1cc(NC(=O)c2ccc3ccc(NC4CCCCNC4)nn23)c(n1)C(F)F Show InChI InChI=1S/C19H23F2N7O.C2HF3O2/c1-27-11-14(17(26-27)18(20)21)24-19(29)15-7-5-13-6-8-16(25-28(13)15)23-12-4-2-3-9-22-10-12;3-2(4,5)1(6)7/h5-8,11-12,18,22H,2-4,9-10H2,1H3,(H,23,25)(H,24,29);(H,6,7)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	2	n/a	n/a	n/a	n/a	7.2	n/a
Merck Sharp & Dohme Corp. US Patent					Assay Description The kinase activity of IRAK4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosp...				US Patent US10040798 (2018) BindingDB Entry DOI: 10.7270/Q2F191Q7
					More data for this Ligand-Target Pair
Interleukin-1 receptor-associated kinase 4 (Homo sapiens (Human))	BDBM278725 (2-{[(1R,2S)-2-amino- cyclohexyl]amino}- N-(3-bromo...) Show SMILES OC(=O)C(F)(F)F.Cn1cc(NC(=O)c2ccc3ccc(N[C@@H]4CCCC[C@@H]4N)nn23)c(Br)n1 |r| Show InChI InChI=1S/C18H22BrN7O.C2HF3O2/c1-25-10-14(17(19)24-25)22-18(27)15-8-6-11-7-9-16(23-26(11)15)21-13-5-3-2-4-12(13)20;3-2(4,5)1(6)7/h6-10,12-13H,2-5,20H2,1H3,(H,21,23)(H,22,27);(H,6,7)/t12-,13+;/m0./s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	2	n/a	n/a	n/a	n/a	7.2	n/a
Merck Sharp & Dohme Corp. US Patent					Assay Description The kinase activity of IRAK4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosp...				US Patent US10040798 (2018) BindingDB Entry DOI: 10.7270/Q2F191Q7
					More data for this Ligand-Target Pair
Interleukin-1 receptor-associated kinase 4 (Homo sapiens (Human))	BDBM278721 (2-(5,8- diazaspiro[2.6]non-5- yl)-N-[3- (difluorom...) Show SMILES OC(=O)C(F)(F)F.Cn1cc(NC(=O)c2ccc3ccc(nn23)N2CCNCC3(CC3)C2)c(n1)C(F)F Show InChI InChI=1S/C20H23F2N7O/c1-27-10-14(17(26-27)18(21)22)24-19(30)15-4-2-13-3-5-16(25-29(13)15)28-9-8-23-11-20(12-28)6-7-20/h2-5,10,18,23H,6-9,11-12H2,1H3,(H,24,30)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	2	n/a	n/a	n/a	n/a	7.2	n/a
Merck Sharp & Dohme Corp. US Patent					Assay Description The kinase activity of IRAK4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosp...				US Patent US10040798 (2018) BindingDB Entry DOI: 10.7270/Q2F191Q7
					More data for this Ligand-Target Pair
Interleukin-1 receptor-associated kinase 4 (Homo sapiens (Human))	BDBM278718 (2-(1,4-diazepan-1-yl)- N-[3-(difluoromethyl)- 1-me...) Show SMILES OC(=O)C(F)(F)F.Cn1cc(NC(=O)c2ccc3ccc(nn23)N2CCCNCC2)c(n1)C(F)F Show InChI InChI=1S/C18H21F2N7O/c1-25-11-13(16(24-25)17(19)20)22-18(28)14-5-3-12-4-6-15(23-27(12)14)26-9-2-7-21-8-10-26/h3-6,11,17,21H,2,7-10H2,1H3,(H,22,28)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	2	n/a	n/a	n/a	n/a	7.2	n/a
Merck Sharp & Dohme Corp. US Patent					Assay Description The kinase activity of IRAK4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosp...				US Patent US10040798 (2018) BindingDB Entry DOI: 10.7270/Q2F191Q7
					More data for this Ligand-Target Pair
Interleukin-1 receptor-associated kinase 4 (Homo sapiens (Human))	BDBM278717 (N-[3-(difluoromethyl)- 1-methyl-1H-pyrazol-4- yl]-...) Show SMILES OC(=O)C(F)(F)F.Cn1cc(NC(=O)c2ccc3ccc(nn23)N2CCNCC2)c(n1)C(F)F Show InChI InChI=1S/C17H19F2N7O/c1-24-10-12(15(23-24)16(18)19)21-17(27)13-4-2-11-3-5-14(22-26(11)13)25-8-6-20-7-9-25/h2-5,10,16,20H,6-9H2,1H3,(H,21,27)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	2	n/a	n/a	n/a	n/a	7.2	n/a
Merck Sharp & Dohme Corp. US Patent					Assay Description The kinase activity of IRAK4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosp...				US Patent US10040798 (2018) BindingDB Entry DOI: 10.7270/Q2F191Q7
					More data for this Ligand-Target Pair
Interleukin-1 receptor-associated kinase 4 (Homo sapiens (Human))	BDBM278818 (2-(3,8- diazabicyclo[3.2.1]oct- 8-yl)-N-[1-methyl-...) Show SMILES OC(=O)C(F)(F)F.Cn1cc(NC(=O)c2ccc3ccc(nn23)N2C3CCC2CNC3)c(n1)C(F)(F)F Show InChI InChI=1S/C19H20F3N7O.C2HF3O2/c1-27-10-14(17(26-27)19(20,21)22)24-18(30)15-6-4-11-5-7-16(25-29(11)15)28-12-2-3-13(28)9-23-8-12;3-2(4,5)1(6)7/h4-7,10,12-13,23H,2-3,8-9H2,1H3,(H,24,30);(H,6,7)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	2	n/a	n/a	n/a	n/a	7.2	n/a
Merck Sharp & Dohme Corp. US Patent					Assay Description The kinase activity of IRAK4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosp...				US Patent US10040798 (2018) BindingDB Entry DOI: 10.7270/Q2F191Q7
					More data for this Ligand-Target Pair
Interleukin-1 receptor-associated kinase 4 (Homo sapiens (Human))	BDBM278787 (2-{[(1R,2S)-2- aminocyclohexyl]amino}- N-(4-chloro...) Show SMILES OC(=O)C(F)(F)F.N[C@H]1CCCC[C@H]1Nc1ccc2ccc(C(=O)Nc3cscc3Cl)n2n1 |r| Show InChI InChI=1S/C18H20ClN5OS.C2HF3O2/c19-12-9-26-10-15(12)22-18(25)16-7-5-11-6-8-17(23-24(11)16)21-14-4-2-1-3-13(14)20;3-2(4,5)1(6)7/h5-10,13-14H,1-4,20H2,(H,21,23)(H,22,25);(H,6,7)/t13-,14+;/m0./s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	2	n/a	n/a	n/a	n/a	7.2	n/a
Merck Sharp & Dohme Corp. US Patent					Assay Description The kinase activity of IRAK4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosp...				US Patent US10040798 (2018) BindingDB Entry DOI: 10.7270/Q2F191Q7
					More data for this Ligand-Target Pair
Interleukin-1 receptor-associated kinase 4 (Homo sapiens (Human))	BDBM278777 (2-{[(1R,2S)-2- aminocyclohexyl]amino}- N-(2-cyanot...) Show SMILES OC(=O)C(F)(F)F.N[C@H]1CCCC[C@H]1Nc1ccc2ccc(C(=O)Nc3ccsc3C#N)n2n1 |r| Show InChI InChI=1S/C19H20N6OS.C2HF3O2/c20-11-17-15(9-10-27-17)23-19(26)16-7-5-12-6-8-18(24-25(12)16)22-14-4-2-1-3-13(14)21;3-2(4,5)1(6)7/h5-10,13-14H,1-4,21H2,(H,22,24)(H,23,26);(H,6,7)/t13-,14+;/m0./s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	2	n/a	n/a	n/a	n/a	7.2	n/a
Merck Sharp & Dohme Corp. US Patent					Assay Description The kinase activity of IRAK4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosp...				US Patent US10040798 (2018) BindingDB Entry DOI: 10.7270/Q2F191Q7
					More data for this Ligand-Target Pair
Interleukin-1 receptor-associated kinase 4 (Homo sapiens (Human))	BDBM278743 (2-[(3R)- or (3S)-azepan- 3-ylamino]-N-[1- methyl-3...) Show SMILES OC(=O)C(F)(F)F.Cn1cc(NC(=O)c2ccc3ccc(N[C@H]4CCCCNC4)nn23)c(n1)C(F)(F)F |r| Show InChI InChI=1S/C19H22F3N7O.C2HF3O2/c1-28-11-14(17(27-28)19(20,21)22)25-18(30)15-7-5-13-6-8-16(26-29(13)15)24-12-4-2-3-9-23-10-12;3-2(4,5)1(6)7/h5-8,11-12,23H,2-4,9-10H2,1H3,(H,24,26)(H,25,30);(H,6,7)/t12-;/m0./s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	2	n/a	n/a	n/a	n/a	7.2	n/a
Merck Sharp & Dohme Corp. US Patent					Assay Description The kinase activity of IRAK4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosp...				US Patent US10040798 (2018) BindingDB Entry DOI: 10.7270/Q2F191Q7
					More data for this Ligand-Target Pair
Interleukin-1 receptor-associated kinase 4 (Homo sapiens (Human))	BDBM278742 (2-[(3R)- or (3S)-azepan- 3-ylamino]-N-[1- methyl-3...) Show SMILES OC(=O)C(F)(F)F.Cn1cc(NC(=O)c2ccc3ccc(N[C@@H]4CCCCNC4)nn23)c(n1)C(F)(F)F |r| Show InChI InChI=1S/C19H22F3N7O.C2HF3O2/c1-28-11-14(17(27-28)19(20,21)22)25-18(30)15-7-5-13-6-8-16(26-29(13)15)24-12-4-2-3-9-23-10-12;3-2(4,5)1(6)7/h5-8,11-12,23H,2-4,9-10H2,1H3,(H,24,26)(H,25,30);(H,6,7)/t12-;/m1./s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	2	n/a	n/a	n/a	n/a	7.2	n/a
Merck Sharp & Dohme Corp. US Patent					Assay Description The kinase activity of IRAK4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosp...				US Patent US10040798 (2018) BindingDB Entry DOI: 10.7270/Q2F191Q7
					More data for this Ligand-Target Pair
Interleukin-1 receptor-associated kinase 4 (Homo sapiens (Human))	BDBM278741 (2-[(1S,4S)- or (1R,4R)- 2,5- diazabicyclo[2.2.2]oc...) Show SMILES OC(=O)C(F)(F)F.Cn1cc(NC(=O)c2ccc3ccc(nn23)N2C[C@H]3CC[C@@H]2CN3)c(n1)C(F)F |r| Show InChI InChI=1S/C19H21F2N7O.C2HF3O2/c1-26-10-14(17(25-26)18(20)21)23-19(29)15-6-4-12-5-7-16(24-28(12)15)27-9-11-2-3-13(27)8-22-11;3-2(4,5)1(6)7/h4-7,10-11,13,18,22H,2-3,8-9H2,1H3,(H,23,29);(H,6,7)/t11-,13-;/m1./s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	2	n/a	n/a	n/a	n/a	7.2	n/a
Merck Sharp & Dohme Corp. US Patent					Assay Description The kinase activity of IRAK4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosp...				US Patent US10040798 (2018) BindingDB Entry DOI: 10.7270/Q2F191Q7
					More data for this Ligand-Target Pair
Interleukin-1 receptor-associated kinase 4 (Homo sapiens (Human))	BDBM278740 (2-[(1S,4S)- or (1R,4R)- 2,5- diazabicyclo[2.2.2]oc...) Show SMILES OC(=O)C(F)(F)F.Cn1cc(NC(=O)c2ccc3ccc(nn23)N2C[C@@H]3CC[C@H]2CN3)c(n1)C(F)F |r| Show InChI InChI=1S/C19H21F2N7O.C2HF3O2/c1-26-10-14(17(25-26)18(20)21)23-19(29)15-6-4-12-5-7-16(24-28(12)15)27-9-11-2-3-13(27)8-22-11;3-2(4,5)1(6)7/h4-7,10-11,13,18,22H,2-3,8-9H2,1H3,(H,23,29);(H,6,7)/t11-,13-;/m0./s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	3	n/a	n/a	n/a	n/a	7.2	n/a
Merck Sharp & Dohme Corp. US Patent					Assay Description The kinase activity of IRAK4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosp...				US Patent US10040798 (2018) BindingDB Entry DOI: 10.7270/Q2F191Q7
					More data for this Ligand-Target Pair
Interleukin-1 receptor-associated kinase 4 (Homo sapiens (Human))	BDBM278775 (2-{[(1R,2S)-2- aminocyclohexyl]amino}- N-(4-cyanot...) Show SMILES OC(=O)C(F)(F)F.N[C@H]1CCCC[C@H]1Nc1ccc2ccc(C(=O)Nc3cscc3C#N)n2n1 |r| Show InChI InChI=1S/C19H20N6OS.C2HF3O2/c20-9-12-10-27-11-16(12)23-19(26)17-7-5-13-6-8-18(24-25(13)17)22-15-4-2-1-3-14(15)21;3-2(4,5)1(6)7/h5-8,10-11,14-15H,1-4,21H2,(H,22,24)(H,23,26);(H,6,7)/t14-,15+;/m0./s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	3	n/a	n/a	n/a	n/a	7.2	n/a
Merck Sharp & Dohme Corp. US Patent					Assay Description The kinase activity of IRAK4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosp...				US Patent US10040798 (2018) BindingDB Entry DOI: 10.7270/Q2F191Q7
					More data for this Ligand-Target Pair
Interleukin-1 receptor-associated kinase 4 (Homo sapiens (Human))	BDBM278752 (2-[(1S,5S)- or (1R,5R)- 3,6- diazabicyclo[3.2.1]oc...) Show SMILES Cn1cc(NC(=O)c2ccc3ccc(nn23)N2C[C@@H]3C[C@H](C2)N3)c(n1)C(F)F |r| Show InChI InChI=1S/C18H19F2N7O/c1-25-9-13(16(24-25)17(19)20)22-18(28)14-4-2-12-3-5-15(23-27(12)14)26-7-10-6-11(8-26)21-10/h2-5,9-11,17,21H,6-8H2,1H3,(H,22,28)/t10-,11+	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	4	n/a	n/a	n/a	n/a	7.2	n/a
Merck Sharp & Dohme Corp. US Patent					Assay Description The kinase activity of IRAK4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosp...				US Patent US10040798 (2018) BindingDB Entry DOI: 10.7270/Q2F191Q7
					More data for this Ligand-Target Pair
Interleukin-1 receptor-associated kinase 4 (Homo sapiens (Human))	BDBM278773 (2-{[(1R,2S)-2- aminocyclohexyl]amino}- N-(2-chloro...) Show SMILES OC(=O)C(F)(F)F.N[C@H]1CCCC[C@H]1Nc1ccc2ccc(C(=O)Nc3ccsc3Cl)n2n1 |r| Show InChI InChI=1S/C18H20ClN5OS.C2HF3O2/c19-17-14(9-10-26-17)22-18(25)15-7-5-11-6-8-16(23-24(11)15)21-13-4-2-1-3-12(13)20;3-2(4,5)1(6)7/h5-10,12-13H,1-4,20H2,(H,21,23)(H,22,25);(H,6,7)/t12-,13+;/m0./s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	4	n/a	n/a	n/a	n/a	7.2	n/a
Merck Sharp & Dohme Corp. US Patent					Assay Description The kinase activity of IRAK4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosp...				US Patent US10040798 (2018) BindingDB Entry DOI: 10.7270/Q2F191Q7
					More data for this Ligand-Target Pair
Interleukin-1 receptor-associated kinase 4 (Homo sapiens (Human))	BDBM278720 (2-(2,5- diazabicyclo[2.2.2]oct- 2-yl)-N-[3- (diflu...) Show SMILES OC(=O)C(F)(F)F.Cn1cc(NC(=O)c2ccc3ccc(nn23)N2CC3CCC2CN3)c(n1)C(F)F Show InChI InChI=1S/C19H21F2N7O.C2HF3O2/c1-26-10-14(17(25-26)18(20)21)23-19(29)15-6-4-12-5-7-16(24-28(12)15)27-9-11-2-3-13(27)8-22-11;3-2(4,5)1(6)7/h4-7,10-11,13,18,22H,2-3,8-9H2,1H3,(H,23,29);(H,6,7)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	4	n/a	n/a	n/a	n/a	7.2	n/a
Merck Sharp & Dohme Corp. US Patent					Assay Description The kinase activity of IRAK4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosp...				US Patent US10040798 (2018) BindingDB Entry DOI: 10.7270/Q2F191Q7
					More data for this Ligand-Target Pair
Interleukin-1 receptor-associated kinase 4 (Homo sapiens (Human))	BDBM278821 (2-[(1S,5R)- or (1R,5S)- 3,6- diazabicyclo[3.2.1]oc...) Show SMILES Cn1cc(NC(=O)c2ccc3ccc(nn23)N2C[C@H]3C[C@@H]2CNC3)c(n1)C(F)F |r| Show InChI InChI=1S/C19H21F2N7O/c1-26-10-14(17(25-26)18(20)21)23-19(29)15-4-2-12-3-5-16(24-28(12)15)27-9-11-6-13(27)8-22-7-11/h2-5,10-11,13,18,22H,6-9H2,1H3,(H,23,29)/t11-,13+/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	5	n/a	n/a	n/a	n/a	7.2	n/a
Merck Sharp & Dohme Corp. US Patent					Assay Description The kinase activity of IRAK4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosp...				US Patent US10040798 (2018) BindingDB Entry DOI: 10.7270/Q2F191Q7
					More data for this Ligand-Target Pair
Interleukin-1 receptor-associated kinase 4 (Homo sapiens (Human))	BDBM278805 (N-(2- cyanophenyl)-2- [(3R)-piperidin-3- ylamino]p...) Show SMILES OC(=O)C(F)(F)F.O=C(Nc1ccccc1C#N)c1ccc2ccc(N[C@@H]3CCCNC3)nn12 |r| Show InChI InChI=1S/C20H20N6O.C2HF3O2/c21-12-14-4-1-2-6-17(14)24-20(27)18-9-7-16-8-10-19(25-26(16)18)23-15-5-3-11-22-13-15;3-2(4,5)1(6)7/h1-2,4,6-10,15,22H,3,5,11,13H2,(H,23,25)(H,24,27);(H,6,7)/t15-;/m1./s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	6	n/a	n/a	n/a	n/a	7.2	n/a
Merck Sharp & Dohme Corp. US Patent					Assay Description The kinase activity of IRAK4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosp...				US Patent US10040798 (2018) BindingDB Entry DOI: 10.7270/Q2F191Q7
					More data for this Ligand-Target Pair
Interleukin-1 receptor-associated kinase 4 (Homo sapiens (Human))	BDBM278767 (2-{[(1R,2S)-2- aminocyclohexyl]amino}- N-(2- chlor...) Show SMILES OC(=O)C(F)(F)F.N[C@H]1CCCC[C@H]1Nc1ccc2ccc(C(=O)Nc3ccccc3Cl)n2n1 |r| Show InChI InChI=1S/C20H22ClN5O.C2HF3O2/c21-14-5-1-3-7-16(14)24-20(27)18-11-9-13-10-12-19(25-26(13)18)23-17-8-4-2-6-15(17)22;3-2(4,5)1(6)7/h1,3,5,7,9-12,15,17H,2,4,6,8,22H2,(H,23,25)(H,24,27);(H,6,7)/t15-,17+;/m0./s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	6	n/a	n/a	n/a	n/a	7.2	n/a
Merck Sharp & Dohme Corp. US Patent					Assay Description The kinase activity of IRAK4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosp...				US Patent US10040798 (2018) BindingDB Entry DOI: 10.7270/Q2F191Q7
					More data for this Ligand-Target Pair
Interleukin-1 receptor-associated kinase 4 (Homo sapiens (Human))	BDBM278806 (2-{[(1R,2S)-2- aminocyclohexyl] amino}-N-(2- cyano...) Show SMILES OC(=O)C(F)(F)F.N[C@H]1CCCC[C@H]1Nc1ccc2ccc(C(=O)Nc3ccccc3C#N)n2n1 |r| Show InChI InChI=1S/C21H22N6O.C2HF3O2/c22-13-14-5-1-3-7-17(14)25-21(28)19-11-9-15-10-12-20(26-27(15)19)24-18-8-4-2-6-16(18)23;3-2(4,5)1(6)7/h1,3,5,7,9-12,16,18H,2,4,6,8,23H2,(H,24,26)(H,25,28);(H,6,7)/t16-,18+;/m0./s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	6	n/a	n/a	n/a	n/a	7.2	n/a
Merck Sharp & Dohme Corp. US Patent					Assay Description The kinase activity of IRAK4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosp...				US Patent US10040798 (2018) BindingDB Entry DOI: 10.7270/Q2F191Q7
					More data for this Ligand-Target Pair
Interleukin-1 receptor-associated kinase 4 (Homo sapiens (Human))	BDBM278809 (2-[(3R)- or (3S)- azepan-3- ylamino]-N-(2- cyanoph...) Show SMILES OC(=O)C(F)(F)F.O=C(Nc1ccccc1C#N)c1ccc2ccc(N[C@H]3CCCCNC3)nn12 |r| Show InChI InChI=1S/C21H22N6O.C2HF3O2/c22-13-15-5-1-2-7-18(15)25-21(28)19-10-8-17-9-11-20(26-27(17)19)24-16-6-3-4-12-23-14-16;3-2(4,5)1(6)7/h1-2,5,7-11,16,23H,3-4,6,12,14H2,(H,24,26)(H,25,28);(H,6,7)/t16-;/m0./s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	7	n/a	n/a	n/a	n/a	7.2	n/a
Merck Sharp & Dohme Corp. US Patent					Assay Description The kinase activity of IRAK4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosp...				US Patent US10040798 (2018) BindingDB Entry DOI: 10.7270/Q2F191Q7
					More data for this Ligand-Target Pair
Interleukin-1 receptor-associated kinase 4 (Homo sapiens (Human))	BDBM278765 (2-{[(1R,2S)-2- aminocyclohexyl]amino}- N-(4-bromot...) Show SMILES OC(=O)C(F)(F)F.N[C@H]1CCCC[C@H]1Nc1ccc2ccc(C(=O)Nc3cscc3Br)n2n1 |r| Show InChI InChI=1S/C18H20BrN5OS.C2HF3O2/c19-12-9-26-10-15(12)22-18(25)16-7-5-11-6-8-17(23-24(11)16)21-14-4-2-1-3-13(14)20;3-2(4,5)1(6)7/h5-10,13-14H,1-4,20H2,(H,21,23)(H,22,25);(H,6,7)/t13-,14+;/m0./s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	7	n/a	n/a	n/a	n/a	7.2	n/a
Merck Sharp & Dohme Corp. US Patent					Assay Description The kinase activity of IRAK4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosp...				US Patent US10040798 (2018) BindingDB Entry DOI: 10.7270/Q2F191Q7
					More data for this Ligand-Target Pair
Interleukin-1 receptor-associated kinase 4 (Homo sapiens (Human))	BDBM278750 (2-(3,8- diazabicyclo[3.2.1]oct- 3-yl)-N-[1-methyl-...) Show SMILES OC(=O)C(F)(F)F.Cn1cc(NC(=O)c2ccc3ccc(nn23)N2CC3CCC(C2)N3)c(n1)C(F)(F)F Show InChI InChI=1S/C19H20F3N7O.C2HF3O2/c1-27-10-14(17(26-27)19(20,21)22)24-18(30)15-6-4-13-5-7-16(25-29(13)15)28-8-11-2-3-12(9-28)23-11;3-2(4,5)1(6)7/h4-7,10-12,23H,2-3,8-9H2,1H3,(H,24,30);(H,6,7)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	9	n/a	n/a	n/a	n/a	7.2	n/a
Merck Sharp & Dohme Corp. US Patent					Assay Description The kinase activity of IRAK4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosp...				US Patent US10040798 (2018) BindingDB Entry DOI: 10.7270/Q2F191Q7
					More data for this Ligand-Target Pair
Interleukin-1 receptor-associated kinase 4 (Homo sapiens (Human))	BDBM278779 (2-{[(1R,2S)-2- aminocyclohexyl]amino}- N-(2-bromot...) Show SMILES OC(=O)C(F)(F)F.N[C@H]1CCCC[C@H]1Nc1ccc2ccc(C(=O)Nc3ccsc3Br)n2n1 |r| Show InChI InChI=1S/C18H20BrN5OS.C2HF3O2/c19-17-14(9-10-26-17)22-18(25)15-7-5-11-6-8-16(23-24(11)15)21-13-4-2-1-3-12(13)20;3-2(4,5)1(6)7/h5-10,12-13H,1-4,20H2,(H,21,23)(H,22,25);(H,6,7)/t12-,13+;/m0./s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	11	n/a	n/a	n/a	n/a	7.2	n/a
Merck Sharp & Dohme Corp. US Patent					Assay Description The kinase activity of IRAK4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosp...				US Patent US10040798 (2018) BindingDB Entry DOI: 10.7270/Q2F191Q7
					More data for this Ligand-Target Pair
Interleukin-1 receptor-associated kinase 4 (Homo sapiens (Human))	BDBM278723 (N-[3-(difluoromethyl)- 1-methyl-1H-pyrazol-4- yl]-...) Show SMILES OC(=O)C(F)(F)F.Cn1cc(NC(=O)c2ccc3ccc(N[C@@H]4CCCC[C@@H]4O)nn23)c(n1)C(F)F |r| Show InChI InChI=1S/C19H22F2N6O2.C2HF3O2/c1-26-10-13(17(25-26)18(20)21)23-19(29)14-8-6-11-7-9-16(24-27(11)14)22-12-4-2-3-5-15(12)28;3-2(4,5)1(6)7/h6-10,12,15,18,28H,2-5H2,1H3,(H,22,24)(H,23,29);(H,6,7)/t12-,15+;/m1./s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	11	n/a	n/a	n/a	n/a	7.2	n/a
Merck Sharp & Dohme Corp. US Patent					Assay Description The kinase activity of IRAK4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosp...				US Patent US10040798 (2018) BindingDB Entry DOI: 10.7270/Q2F191Q7
					More data for this Ligand-Target Pair
Interleukin-1 receptor-associated kinase 4 (Homo sapiens (Human))	BDBM278760 (2-{[(1R,2S)-2- aminocyclohexyl]amino}- N-(2-bromo-...) Show SMILES OC(=O)C(F)(F)F.N[C@H]1CCCC[C@H]1Nc1ccc2ccc(C(=O)Nc3ccccc3Br)n2n1 |r| Show InChI InChI=1S/C20H22BrN5O.C2HF3O2/c21-14-5-1-3-7-16(14)24-20(27)18-11-9-13-10-12-19(25-26(13)18)23-17-8-4-2-6-15(17)22;3-2(4,5)1(6)7/h1,3,5,7,9-12,15,17H,2,4,6,8,22H2,(H,23,25)(H,24,27);(H,6,7)/t15-,17+;/m0./s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	11	n/a	n/a	n/a	n/a	7.2	n/a
Merck Sharp & Dohme Corp. US Patent					Assay Description The kinase activity of IRAK4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosp...				US Patent US10040798 (2018) BindingDB Entry DOI: 10.7270/Q2F191Q7
					More data for this Ligand-Target Pair
Interleukin-1 receptor-associated kinase 4 (Homo sapiens (Human))	BDBM278752 (2-[(1S,5S)- or (1R,5R)- 3,6- diazabicyclo[3.2.1]oc...) Show SMILES Cn1cc(NC(=O)c2ccc3ccc(nn23)N2C[C@@H]3C[C@H](C2)N3)c(n1)C(F)F |r| Show InChI InChI=1S/C18H19F2N7O/c1-25-9-13(16(24-25)17(19)20)22-18(28)14-4-2-12-3-5-15(23-27(12)14)26-7-10-6-11(8-26)21-10/h2-5,9-11,17,21H,6-8H2,1H3,(H,22,28)/t10-,11+	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	12	n/a	n/a	n/a	n/a	7.2	n/a
Merck Sharp & Dohme Corp. US Patent					Assay Description The kinase activity of IRAK4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosp...				US Patent US10040798 (2018) BindingDB Entry DOI: 10.7270/Q2F191Q7
					More data for this Ligand-Target Pair
Interleukin-1 receptor-associated kinase 4 (Homo sapiens (Human))	BDBM278822 (2-[(1S,5R)- or (1R,5S)- 3,6- diazabicyclo[3.2.1]oc...) Show SMILES Cn1cc(NC(=O)c2ccc3ccc(nn23)N2C[C@@H]3C[C@H]2CNC3)c(n1)C(F)F |r| Show InChI InChI=1S/C19H21F2N7O/c1-26-10-14(17(25-26)18(20)21)23-19(29)15-4-2-12-3-5-16(24-28(12)15)27-9-11-6-13(27)8-22-7-11/h2-5,10-11,13,18,22H,6-9H2,1H3,(H,23,29)/t11-,13+/m1/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	14	n/a	n/a	n/a	n/a	7.2	n/a
Merck Sharp & Dohme Corp. US Patent					Assay Description The kinase activity of IRAK4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosp...				US Patent US10040798 (2018) BindingDB Entry DOI: 10.7270/Q2F191Q7
					More data for this Ligand-Target Pair
Interleukin-1 receptor-associated kinase 4 (Homo sapiens (Human))	BDBM278737 (N-(3-chloro-1-methyl- 1H-pyrazol-4-yl)-2- [(1S,4S)...) Show SMILES OC(=O)C(F)(F)F.Cn1cc(NC(=O)c2ccc3ccc(nn23)N2C[C@H]3CC[C@@H]2CN3)c(Cl)n1 |r| Show InChI InChI=1S/C18H20ClN7O.C2HF3O2/c1-24-10-14(17(19)23-24)21-18(27)15-6-4-12-5-7-16(22-26(12)15)25-9-11-2-3-13(25)8-20-11;3-2(4,5)1(6)7/h4-7,10-11,13,20H,2-3,8-9H2,1H3,(H,21,27);(H,6,7)/t11-,13-;/m1./s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	15	n/a	n/a	n/a	n/a	7.2	n/a
Merck Sharp & Dohme Corp. US Patent					Assay Description The kinase activity of IRAK4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosp...				US Patent US10040798 (2018) BindingDB Entry DOI: 10.7270/Q2F191Q7
					More data for this Ligand-Target Pair
Interleukin-1 receptor-associated kinase 4 (Homo sapiens (Human))	BDBM278711 (2-(2,5- diazabicyclo[2.2.2]oct- 2-yl)-N-[1-methyl-...) Show SMILES Cn1cc(NC(=O)c2ccc3ccc(nn23)N2CC3CCC2CN3)c(n1)C(F)(F)F Show InChI InChI=1S/C19H20F3N7O/c1-27-10-14(17(26-27)19(20,21)22)24-18(30)15-6-4-12-5-7-16(25-29(12)15)28-9-11-2-3-13(28)8-23-11/h4-7,10-11,13,23H,2-3,8-9H2,1H3,(H,24,30)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	19	n/a	n/a	n/a	n/a	7.2	n/a
Merck Sharp & Dohme Corp. US Patent					Assay Description The kinase activity of IRAK4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosp...				US Patent US10040798 (2018) BindingDB Entry DOI: 10.7270/Q2F191Q7
					More data for this Ligand-Target Pair
Interleukin-1 receptor-associated kinase 4 (Homo sapiens (Human))	BDBM278726 (N-(3-chloro-1-methyl- 1H-pyrazol-4-yl)-2- (1,4-dia...) Show SMILES OC(=O)C(F)(F)F.Cn1cc(NC(=O)c2ccc3ccc(nn23)N2CCCNCC2)c(Cl)n1 Show InChI InChI=1S/C17H20ClN7O/c1-23-11-13(16(18)22-23)20-17(26)14-5-3-12-4-6-15(21-25(12)14)24-9-2-7-19-8-10-24/h3-6,11,19H,2,7-10H2,1H3,(H,20,26)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	20	n/a	n/a	n/a	n/a	7.2	n/a
Merck Sharp & Dohme Corp. US Patent					Assay Description The kinase activity of IRAK4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosp...				US Patent US10040798 (2018) BindingDB Entry DOI: 10.7270/Q2F191Q7
					More data for this Ligand-Target Pair
Interleukin-1 receptor-associated kinase 4 (Homo sapiens (Human))	BDBM278739 (N-(3-bromo-1-methyl- 1H-pyrazol-4-yl)-2- [(1S,4S)-...) Show SMILES OC(=O)C(F)(F)F.Cn1cc(NC(=O)c2ccc3ccc(nn23)N2C[C@H]3CC[C@@H]2CN3)c(Br)n1 |r| Show InChI InChI=1S/C18H20BrN7O.C2HF3O2/c1-24-10-14(17(19)23-24)21-18(27)15-6-4-12-5-7-16(22-26(12)15)25-9-11-2-3-13(25)8-20-11;3-2(4,5)1(6)7/h4-7,10-11,13,20H,2-3,8-9H2,1H3,(H,21,27);(H,6,7)/t11-,13-;/m1./s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	22	n/a	n/a	n/a	n/a	7.2	n/a
Merck Sharp & Dohme Corp. US Patent					Assay Description The kinase activity of IRAK4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosp...				US Patent US10040798 (2018) BindingDB Entry DOI: 10.7270/Q2F191Q7
					More data for this Ligand-Target Pair
Interleukin-1 receptor-associated kinase 4 (Homo sapiens (Human))	BDBM278774 (2-{[(1R,2S)-2- aminocyclohexyl]amino}- N-[4- (difl...) Show SMILES OC(=O)C(F)(F)F.N[C@H]1CCCC[C@H]1Nc1ccc2ccc(C(=O)Nc3cscc3C(F)F)n2n1 |r| Show InChI InChI=1S/C19H21F2N5OS.C2HF3O2/c20-18(21)12-9-28-10-15(12)24-19(27)16-7-5-11-6-8-17(25-26(11)16)23-14-4-2-1-3-13(14)22;3-2(4,5)1(6)7/h5-10,13-14,18H,1-4,22H2,(H,23,25)(H,24,27);(H,6,7)/t13-,14+;/m0./s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	24	n/a	n/a	n/a	n/a	7.2	n/a
Merck Sharp & Dohme Corp. US Patent					Assay Description The kinase activity of IRAK4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosp...				US Patent US10040798 (2018) BindingDB Entry DOI: 10.7270/Q2F191Q7
					More data for this Ligand-Target Pair
Interleukin-1 receptor-associated kinase 4 (Homo sapiens (Human))	BDBM278730 (N-(3-bromo-1-methyl- 1H-pyrazol-4-yl)-2- (2,5- dia...) Show SMILES OC(=O)C(F)(F)F.Cn1cc(NC(=O)c2ccc3ccc(nn23)N2CC3CCC2CN3)c(Br)n1 Show InChI InChI=1S/C18H20BrN7O.C2HF3O2/c1-24-10-14(17(19)23-24)21-18(27)15-6-4-12-5-7-16(22-26(12)15)25-9-11-2-3-13(25)8-20-11;3-2(4,5)1(6)7/h4-7,10-11,13,20H,2-3,8-9H2,1H3,(H,21,27);(H,6,7)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	24	n/a	n/a	n/a	n/a	7.2	n/a
Merck Sharp & Dohme Corp. US Patent					Assay Description The kinase activity of IRAK4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosp...				US Patent US10040798 (2018) BindingDB Entry DOI: 10.7270/Q2F191Q7
					More data for this Ligand-Target Pair
Interleukin-1 receptor-associated kinase 4 (Homo sapiens (Human))	BDBM278746 (N-(3-cyano-1-methyl- 1H-pyrazol-4-yl)-2- [(1S,4S)-...) Show SMILES OC(=O)C(F)(F)F.Cn1cc(NC(=O)c2ccc3ccc(nn23)N2C[C@@H]3CC[C@H]2CN3)c(n1)C#N |r| Show InChI InChI=1S/C19H20N8O.C2HF3O2/c1-25-11-16(15(8-20)23-25)22-19(28)17-6-4-13-5-7-18(24-27(13)17)26-10-12-2-3-14(26)9-21-12;3-2(4,5)1(6)7/h4-7,11-12,14,21H,2-3,9-10H2,1H3,(H,22,28);(H,6,7)/t12-,14-;/m0./s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	25	n/a	n/a	n/a	n/a	7.2	n/a
Merck Sharp & Dohme Corp. US Patent					Assay Description The kinase activity of IRAK4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosp...				US Patent US10040798 (2018) BindingDB Entry DOI: 10.7270/Q2F191Q7
					More data for this Ligand-Target Pair
Interleukin-1 receptor-associated kinase 4 (Homo sapiens (Human))	BDBM278734 (N-(3-cyano-1-methyl- 1H-pyrazol-4-yl)-2- (2,5- dia...) Show SMILES OC(=O)C(F)(F)F.Cn1cc(NC(=O)c2ccc3ccc(nn23)N2CC3CCC2CN3)c(n1)C#N Show InChI InChI=1S/C19H20N8O.C2HF3O2/c1-25-11-16(15(8-20)23-25)22-19(28)17-6-4-13-5-7-18(24-27(13)17)26-10-12-2-3-14(26)9-21-12;3-2(4,5)1(6)7/h4-7,11-12,14,21H,2-3,9-10H2,1H3,(H,22,28);(H,6,7)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	25	n/a	n/a	n/a	n/a	7.2	n/a
Merck Sharp & Dohme Corp. US Patent					Assay Description The kinase activity of IRAK4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosp...				US Patent US10040798 (2018) BindingDB Entry DOI: 10.7270/Q2F191Q7
					More data for this Ligand-Target Pair
Interleukin-1 receptor-associated kinase 4 (Homo sapiens (Human))	BDBM278807 (2-[(3R)-3- aminopiperidin-1- yl]-N-(2-cyanophenyl)...) Show SMILES OC(=O)C(F)(F)F.N[C@@H]1CCCN(C1)c1ccc2ccc(C(=O)Nc3ccccc3C#N)n2n1 |r| Show InChI InChI=1S/C20H20N6O.C2HF3O2/c21-12-14-4-1-2-6-17(14)23-20(27)18-9-7-16-8-10-19(24-26(16)18)25-11-3-5-15(22)13-25;3-2(4,5)1(6)7/h1-2,4,6-10,15H,3,5,11,13,22H2,(H,23,27);(H,6,7)/t15-;/m1./s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	26	n/a	n/a	n/a	n/a	7.2	n/a
Merck Sharp & Dohme Corp. US Patent					Assay Description The kinase activity of IRAK4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosp...				US Patent US10040798 (2018) BindingDB Entry DOI: 10.7270/Q2F191Q7
					More data for this Ligand-Target Pair
Interleukin-1 receptor-associated kinase 4 (Homo sapiens (Human))	BDBM278711 (2-(2,5- diazabicyclo[2.2.2]oct- 2-yl)-N-[1-methyl-...) Show SMILES Cn1cc(NC(=O)c2ccc3ccc(nn23)N2CC3CCC2CN3)c(n1)C(F)(F)F Show InChI InChI=1S/C19H20F3N7O/c1-27-10-14(17(26-27)19(20,21)22)24-18(30)15-6-4-12-5-7-16(25-29(12)15)28-9-11-2-3-13(28)8-23-11/h4-7,10-11,13,23H,2-3,8-9H2,1H3,(H,24,30)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	27	n/a	n/a	n/a	n/a	7.2	n/a
Merck Sharp & Dohme Corp. US Patent					Assay Description The kinase activity of IRAK4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosp...				US Patent US10040798 (2018) BindingDB Entry DOI: 10.7270/Q2F191Q7
					More data for this Ligand-Target Pair
Interleukin-1 receptor-associated kinase 4 (Homo sapiens (Human))	BDBM278712 (2-(5,8- diazaspiro[2.6]non-5- yl)-N-[1-methyl-3- (...) Show SMILES OC(=O)C(F)(F)F.Cn1cc(NC(=O)c2ccc3ccc(nn23)N2CCNCC3(CC3)C2)c(n1)C(F)(F)F Show InChI InChI=1S/C20H22F3N7O/c1-28-10-14(17(27-28)20(21,22)23)25-18(31)15-4-2-13-3-5-16(26-30(13)15)29-9-8-24-11-19(12-29)6-7-19/h2-5,10,24H,6-9,11-12H2,1H3,(H,25,31)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	27	n/a	n/a	n/a	n/a	7.2	n/a
Merck Sharp & Dohme Corp. US Patent					Assay Description The kinase activity of IRAK4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosp...				US Patent US10040798 (2018) BindingDB Entry DOI: 10.7270/Q2F191Q7
					More data for this Ligand-Target Pair
Interleukin-1 receptor-associated kinase 4 (Homo sapiens (Human))	BDBM278733 (N-(3-cyano-1-methyl- 1H-pyrazol-4-yl)-2- (1,4-diaz...) Show SMILES OC(=O)C(F)(F)F.Cn1cc(NC(=O)c2ccc3ccc(nn23)N2CCCNCC2)c(n1)C#N Show InChI InChI=1S/C18H20N8O/c1-24-12-15(14(11-19)22-24)21-18(27)16-5-3-13-4-6-17(23-26(13)16)25-9-2-7-20-8-10-25/h3-6,12,20H,2,7-10H2,1H3,(H,21,27)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	27	n/a	n/a	n/a	n/a	7.2	n/a
Merck Sharp & Dohme Corp. US Patent					Assay Description The kinase activity of IRAK4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosp...				US Patent US10040798 (2018) BindingDB Entry DOI: 10.7270/Q2F191Q7
					More data for this Ligand-Target Pair

Displayed 1 to 50 (of 117 total )  |  Next  |  Last  >>

Jump to: